The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein - PubMed (original) (raw)
. 1989 Sep 14;341(6238):162-4.
doi: 10.1038/341162a0.
Affiliations
- PMID: 2779654
- DOI: 10.1038/341162a0
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein
U Beisiegel et al. Nature. 1989.
Abstract
The low-density-lipoprotein (LDL) receptor is a cell-surface protein that plays an important part in the metabolism of cholesterol by mediating the uptake of LDL from plasma into cells. Although LDL particles bind to the LDL receptor through their apolipoprotein B (apo B) and apolipoprotein E (apo E) moieties, other apo E-containing particles, like chylomicron remnants, are not dependent on the LDL receptor for uptake into cells. Chylomicrons formed in the intestinal mucosa during the absorption of the products of digestion, are processed by the peripheral circulation by lipoprotein lipase, which catalyses the breakdown of triglycerides in chylomicrons to free fatty acids and glycerol. The resulting chylomicron remnants, which are cholesterol-rich lipoproteins, are subsequently taken up in the liver. A second distinct protein that binds to apo E-containing lipoproteins, but not to LDL, has been proposed to be the receptor mediating the clearance of chylomicron remnants from the plasma. This protein has a relative molecular mass (Mr) of 56,000 (56K). More recent studies have failed, however, to establish whether this protein is a cell-surface receptor. Here we describe crosslinking experiments in which apo E liposomes were found to bind specifically to the cell surface of hepG2 cells and to human liver membranes. The size and immunological cross-reactivity of the protein to which the liposomes bound was indistinguishable from that of the recently cloned and sequenced LDL-receptor-related protein, LRP. We therefore conclude that the LRP might function as an apo E receptor.
Similar articles
- Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake.
Mahley RW, Hui DY, Innerarity TL, Beisiegel U. Mahley RW, et al. Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I14-8. Arteriosclerosis. 1989. PMID: 2536272 - Interaction of apo E-containing lipoproteins with the LDL-receptor-related protein, LRP.
Harrach-Ruprecht B, Küchenhoff A, Robenek H. Harrach-Ruprecht B, et al. Z Gastroenterol. 1996 Jun;34 Suppl 3:122-3. Z Gastroenterol. 1996. PMID: 8767486 - Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
Al-Haideri M, Goldberg IJ, Galeano NF, Gleeson A, Vogel T, Gorecki M, Sturley SL, Deckelbaum RJ. Al-Haideri M, et al. Biochemistry. 1997 Oct 21;36(42):12766-72. doi: 10.1021/bi9631024. Biochemistry. 1997. PMID: 9335533 - Lipoprotein receptors.
Lestavel S, Fruchart JC. Lestavel S, et al. Cell Mol Biol (Noisy-le-grand). 1994 Jun;40(4):461-81. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 8061563 Review. - Receptor interactions controlling lipoprotein metabolism.
Weisgraber KH, Innerarity TL, Rall SC Jr, Mahley RW. Weisgraber KH, et al. Can J Biochem Cell Biol. 1985 Aug;63(8):898-905. doi: 10.1139/o85-111. Can J Biochem Cell Biol. 1985. PMID: 2998579 Review.
Cited by
- Nucleotide polymorphism-based study utilizes human plasma liposomes to discover potential therapeutic targets for intervertebral disc disease.
Chen DQ, Que ZQ, Xu WB, Xiao KY, Sun NK, Song HY, Feng JY, Lin GX, Rui G. Chen DQ, et al. Front Endocrinol (Lausanne). 2024 Aug 15;15:1403523. doi: 10.3389/fendo.2024.1403523. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39211445 Free PMC article. - Novel insights into the multifaceted and tissue-specific roles of the endocytic receptor LRP1.
Yamamoto K, Scilabra SD, Bonelli S, Jensen A, Scavenius C, Enghild JJ, Strickland DK. Yamamoto K, et al. J Biol Chem. 2024 Aug;300(8):107521. doi: 10.1016/j.jbc.2024.107521. Epub 2024 Jun 29. J Biol Chem. 2024. PMID: 38950861 Free PMC article. Review. - The Role of Apolipoproteins in the Commonest Cancers: A Review.
Darwish NM, Al-Hail MK, Mohamed Y, Al Saady R, Mohsen S, Zar A, Al-Mansoori L, Pedersen S. Darwish NM, et al. Cancers (Basel). 2023 Nov 24;15(23):5565. doi: 10.3390/cancers15235565. Cancers (Basel). 2023. PMID: 38067270 Free PMC article. Review. - Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases.
Yu H, Zaveri S, Sattar Z, Schaible M, Perez Gandara B, Uddin A, McGarvey LR, Ohlmeyer M, Geraghty P. Yu H, et al. Medicina (Kaunas). 2023 Aug 26;59(9):1552. doi: 10.3390/medicina59091552. Medicina (Kaunas). 2023. PMID: 37763671 Free PMC article. Review. - ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury.
Laskowitz DT, Van Wyck DW. Laskowitz DT, et al. Neurotherapeutics. 2023 Oct;20(6):1496-1507. doi: 10.1007/s13311-023-01413-0. Epub 2023 Aug 17. Neurotherapeutics. 2023. PMID: 37592168 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous